Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/174366
Title: Determinants and Functions of CAFs Secretome During Cancer Progression and Therapy
Author: Linares, Jenniffer
Marín Jiménez, Juan A.
Badia Ramentol, Jordi
Calon, Alexandre
Keywords: Càncer
Tractament adjuvant del càncer
Metàstasi
Cancer
Adjuvant treatment of cancer
Metastasis
Issue Date: 22-Jan-2021
Publisher: Frontiers Media
Abstract: Multiple lines of evidence are indicating that cancer development and malignant progression are not exclusively epithelial cancer cell-autonomous processes but may also depend on crosstalk with the surrounding tumor microenvironment (TME). Cancer-associated fibroblasts (CAFs) are abundantly represented in the TME and are continuously interacting with cancer cells. CAFs are regulating key mechanisms during progression to metastasis and response to treatment by enhancing cancer cells survival and aggressiveness. The latest advances in CAFs biology are pointing to CAFs-secreted factors as druggable targets and companion tools for cancer diagnosis and prognosis. Especially, extensive research conducted in the recent years has underscored the potential of several cytokines as actionable biomarkers that are currently evaluated in the clinical setting. In this review, we explore the current understanding of CAFs secretome determinants and functions to discuss their clinical implication in oncology.
Note: Reproducció del document publicat a: https://doi.org/10.3389/fcell.2020.621070
It is part of: Frontiers in Cell and Developmental Biology, 2021, vol. 8
URI: http://hdl.handle.net/2445/174366
Related resource: https://doi.org/10.3389/fcell.2020.621070
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
fcell-08-621070.pdf2.04 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons